SCHEMBL4134420

SCHEMBL4134420

CCOC(=O)C1CCN(c2ccc(C(F)(F)F)cc2)CC1.OCC1CCN(c2ccc(C(F)(F)F)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.57
LGMN Q99538 2/20 0.53
PDK2 Q15119 1/20 0.52
NOTUM Q6P988 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 2/20 0.48
CHRM2 P08172 1/20 0.46
DEGS1 O15121 1/20 0.44
PTGES O14684 2/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2167020 0.93 MAPT (0.64) MAPTLGMNPDK2NOTUMMEN1
SCHEMBL2166648 0.83 HRH4 (0.56) NOTUMCHRM2DEGS1PTGES
SCHEMBL988274 0.82 MEN1 (0.66) MAPTLGMNPDK2MEN1KMT2A
SCHEMBL12631704 0.81 NOTUM (0.49) MAPTNOTUMALDH1A1KDM4ECHRM2
SCHEMBL12631724 0.81 NOTUM (0.55) MAPTLGMNPDK2NOTUMALDH1A1
SCHEMBL6528497 0.81 LGMN (0.56) MAPTLGMNPDK2MEN1KMT2A
SCHEMBL6506137 0.79 NOTUM (0.61) MAPTLGMNPDK2NOTUMMEN1
SCHEMBL1749330 0.79 MAPT (0.68) MAPTLGMNPDK2NOTUMMEN1
SCHEMBL21542280 0.79 NOTUM (0.62) MAPTPDK2NOTUMMEN1KMT2A
SCHEMBL15850037 0.79 MAPT (0.71) MAPTLGMNPDK2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069316-A1 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY Families of Spinal Muscular Atrophy (US) 2009-06-17 EP disclosed
WO-2008016973-A1 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY FAMILIES OF SPINAL MUSCULAR ATROPHY (US) 2008-02-07 WO disclosed